Biohaven Ltd. (NYSE:BHVN) stock is trading higher on Friday following an update with respect to its New Drug Application for ...

Biohaven (NYSE:BHVN) shares spiked in the premarket on Friday after the FDA revoked an advisory committee meeting scheduled ...

Biohaven stock surged early Friday after the FDA canceled an upcoming meeting to discuss the benefits and risks of its drug, ...

Biohaven (BHVN) is jumping 10% after the FDA agreed to review the company’s potential treatment for a rare disease. The FDA’s Decision on BHVN’s Drug Candidate The FDA agreed to review BHVN ...

Investors in Biohaven Ltd (Symbol: BHVN) saw new options become available today, for the May 17th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is ...

Biohaven Ltd. (BHVN) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire LOS ANGELES, July 28, 2025 ...

The average one-year price target for Biohaven (NYSE:BHVN) has been revised to 34.34 / share. This is an increase of 19.39% from the prior estimate of 28.76 dated October 31, 2023. The price ...